Advertisement

Comparison of Two Anticoagulants for Pain Associated with Platelet-Rich Plasma Injections

  • Metin GörgüEmail author
  • Ali Gökkaya
  • Ali Doğan
Original Article Non-Surgical Aesthetic
  • 30 Downloads

Abstract

Background and Aim

Platelet-rich plasma (PRP) has long been used in skin rejuvenation and hair loss treatment. Some patients require multiple intradermal injections into the face and scalp, and the way in which these patients process and experience pain differs, depending on the patient. Minimizing pain and discomfort during nonsurgical procedures is essential for patient satisfaction. In our experience, the use of acid citrate dextrose-A (ACD-A) as an anticoagulant caused more patient discomfort than did sodium citrate (Na-citrate) among patients who underwent facial rejuvenation with PRP. The aim of the present study was to evaluate patient-related discomfort in PRP sessions using two different anticoagulants.

Materials and Methods

This clinical trial included 10 patients who received facial PRP injections for facial rejuvenation and 10 patients who received PRP injections in their scalps for hair loss. On the application area, half the surface was treated with Na-citrate PRP injections, and the other half was treated with the same amount of ACD-A PRP injections. Neither the doctors who applied the treatment nor the patients were given information about which anticoagulant was used in each area. Immediately after the procedure, the patients were asked to score their pain on each side of the application area on a scale of 1–10 using a visual analog scale (VAS).

Results

PRP injections using Na-citrate as an anticoagulant caused less discomfort on both the face and scalp as compared with that of ACD-A. The outcome was statistically significant.

Conclusion

Anticoagulants used in PRP preparation affected patients’ pain perceptions during the injections. The sensation of pain with PRP prepared with Na-citrate as an anticoagulant was lower than that of PRP prepared with ACD-A. Further studies are required to evaluate the correlation between anticoagulants used for PRP preparation and pain feelings during injections.

Level of Evidence III

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.

Keywords

PRP Platelet-rich plasma Anticoagulant Pain 

Notes

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflicts of interest to disclose.

Ethical Approval

This study has Bolu Abant Izzet Baysal University Clinical Researches Ethics Committee Approval (2019/99).

Informed Consent

All participants signed an informed consent forms for this study.

References

  1. 1.
    Dhurat R, Sukesh M (2014) Principles and methods of preparation of platelet-rich plasma: a review and author’s perspective. J Cutan Aesthet Surg 7(4):189–197.  https://doi.org/10.4103/0974-2077.150734 CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Marx RE (2004) Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 62(4):489–496CrossRefGoogle Scholar
  3. 3.
    Russell RP, Apostolakos J, Hirose T et al (2013) Variability of platelet-rich plasma preparations. Sports Med Arthrosc Rev 21(4):186–190.  https://doi.org/10.1097/JSA.0000000000000007 CrossRefPubMedGoogle Scholar
  4. 4.
    Dohan Ehrenfest DM, Rasmusson L, Albrektsson T (2009) Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 27(3):158–167.  https://doi.org/10.1016/j.tibtech.2008.11.009 CrossRefPubMedGoogle Scholar
  5. 5.
    Anitua E (1999) Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants 14(4):529–535PubMedGoogle Scholar
  6. 6.
    Fouché JJ, Van Loghem JAJ, Thuis J, De Heer LM, van Oijen MGH (2017) Left/right pain asymmetry with injectable cosmetic treatments for the face. Aesthet Surg J 37(6):708–714.  https://doi.org/10.1093/asj/sjw214 CrossRefPubMedGoogle Scholar
  7. 7.
    Taddio A, Ilersich AL, Ipp M, Kikuta A, Shah V, HELPinKIDS Team (2009) Physical interventions and injection techniques for reducing injection pain during routine childhood immunizations: systematic review of randomized controlled trials and quasi-randomized controlled trials. Clin Ther 31(Suppl 2):S48–S76.  https://doi.org/10.1016/j.clinthera.2009.07.024 CrossRefPubMedGoogle Scholar
  8. 8.
    Sezgin B, Ozel B, Bulam H, Guney K, Tuncer S, Cenetoglu S (2014) The effect of microneedle thickness on pain during minimally invasive facial procedures: a clinical study. Aesthet Surg J 34(5):757–765.  https://doi.org/10.1177/1090820X14532941 CrossRefPubMedGoogle Scholar
  9. 9.
    Lei H, Gui L, Xiao R (2009) The effect of anticoagulants on the quality and biological efficacy of platelet-rich plasma. Clin Biochem 42(13–14):1452–1460.  https://doi.org/10.1016/j.clinbiochem.2009.06.012 CrossRefPubMedGoogle Scholar
  10. 10.
    Xian LJ, Chowdhury SR, Bin Saim A, Idrus RB (2015) Concentration-dependent effect of platelet-rich plasma on keratinocyte and fibroblast wound healing. Cytotherapy 17(3):293–300.  https://doi.org/10.1016/j.jcyt.2014.10.005 CrossRefPubMedGoogle Scholar
  11. 11.
    Choi BH, Zhu SJ, Kim BY et al (2005) Effect of platelet-rich plasma (PRP) concentration on the viability and proliferation of alveolar bone cells: an in vitro study. Int J Oral Maxillofac Surg 34:420–424CrossRefGoogle Scholar
  12. 12.
    Graziani F, Ivanovski S, Cei S, Ducci F, Tonetti M, Gabriele M (2006) The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin Oral Implants Res 17(2):212–219CrossRefGoogle Scholar
  13. 13.
    Yoshida R, Cheng M, Murray MM (2014) Increasing platelet concentration in platelet-rich plasma inhibits anterior cruciate ligament cell function in three-dimensional culture. J Orthop Res 32(2):291–295.  https://doi.org/10.1002/jor.22493 CrossRefPubMedGoogle Scholar
  14. 14.
    Arora S, Doda V, Kotwal U et al (2016) Quantification of platelets and platelet derived growth factors from platelet-rich-plasma (PRP) prepared at different centrifugal force (g) and time. Transfus Apher Sci 54(1):103–110.  https://doi.org/10.1016/j.transci.2016.01.028 CrossRefPubMedGoogle Scholar
  15. 15.
    Franco D, Franco T, Schettino AM et al (2012) Protocol for obtaining platelet-rich plasma (PRP), platelet-poor plasma (PPP), and thrombin for autologous use. Aesthetic Plast Surg 36(5):1254–1259.  https://doi.org/10.1007/s00266-012-9957-3 CrossRefPubMedGoogle Scholar
  16. 16.
    Araki J, Jona M, Eto H et al (2012) Optimized preparation method of platelet-concentrated plasma and noncoagulating platelet-derived factor concentrates: maximization of platelet concentration and removal of fibrinogen. Tissue Eng C Methods 18(3):176–185.  https://doi.org/10.1089/ten.TEC.2011.0308 CrossRefGoogle Scholar
  17. 17.
    Perez AG, Lana JF, Rodrigues AA et al (2014) Relevant aspects of centrifugation step in the preparation of platelet-rich plasma. ISRN Hematol 25(2014):176060.  https://doi.org/10.1155/2014/176060 CrossRefGoogle Scholar
  18. 18.
    Kobayashi E, Flückiger L, Fujioka-Kobayashi M, Sawada K, Sculean A, Schaller B, Miron RJ (2016) Comparative release of growth factors from PRP, PRF, and advanced-PRF. Clin Oral Investig 20(9):2353–2360.  https://doi.org/10.1007/s00784-016-1719-1 CrossRefPubMedGoogle Scholar
  19. 19.
    Mazzucco L, Balbo V, Cattana E, Guaschino R, Borzini P (2009) Not every PRP-gel is born equal. Evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinet, RegenPRP-Kit, Plateltex and one manual procedure. Vox Sang 97(2):110–118.  https://doi.org/10.1111/j.1423-04https://doi.org/10.2009.01188.x
  20. 20.
    Lippi G, Salvagno GL, Montagnana M, Poli G, Guidi GC (2006) Influence of the needle bore size on platelet count and routine coagulation testing. Blood Coagul Fibrinolysis 17(7):557–561CrossRefGoogle Scholar
  21. 21.
    Sclafani AP, Azzi J (2015) Platelet preparations for use in facial rejuvenation and wound healing: a critical review of current literature. Aesthet Plast Surg 39(4):495–505.  https://doi.org/10.1007/s00266-015-0504-x CrossRefGoogle Scholar
  22. 22.
    Foster TE, Puskas BL, Mandelbaum BR et al (2009) Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med 37(11):2259–2272.  https://doi.org/10.1177/0363546509349921 CrossRefGoogle Scholar
  23. 23.
    Bausset O, Giraudo L, Veran J et al (2012) Formulation and storage of platelet-rich plasma homemade product. Biores Open Access 1(3):115–123.  https://doi.org/10.1089/biores.2012.0225 CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Singh S (2018) Comparative (quantitative and qualitative) analysis of three different reagents for preparation of platelet-rich plasma for hair rejuvenation. J Cutan Aesthet Surg 11(3):127–131.  https://doi.org/10.4103/JCAS.JCAS_108_18 CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Giraldo CE, Álvarez ME, Carmona JU (2015) Effects of sodium citrate and acid citrate dextrose solutions on cell counts and growth factor release from equine pure-platelet rich plasma and pure-platelet rich gel. BMC Vet Res 14(11):60.  https://doi.org/10.1186/s12917-015-0370-4 CrossRefGoogle Scholar
  26. 26.
    Callan MB, Shofer FS, Catalfamo JL (2009) Effects of anticoagulant on pH, ionized calcium concentration, and agonist-induced platelet aggregation in canine platelet-rich plasma. Am J Vet Res 70(4):472–477.  https://doi.org/10.2460/ajvr.70.4.472 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature and International Society of Aesthetic Plastic Surgery 2019

Authors and Affiliations

  1. 1.Department of Plastic, Reconstructive and Aesthetic SurgeryAbant Izzet Baysal UniversityGölköy, BoluTurkey

Personalised recommendations